BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 17335739)

  • 1. [Legal framework for the use of autologous blood and other alternatives to allogenic transfusion].
    Muñoz M; García-Erce JA; Campos A; Fernando Barrios L
    Med Clin (Barc); 2007 Feb; 128(7):256-62. PubMed ID: 17335739
    [No Abstract]   [Full Text] [Related]  

  • 2. [The "Seville" Consensus Document on Alternatives to Allogenic Blood Transfusion. Sociedades españolas de Anestesiología (SEDAR), Medicina Intensiva (SEMICYUC), Hematología y Hemoterapia (AEHH), Transfusión sanguínea (SETS) Trombosis y Hemostasia (SETH)].
    Alberca I; Asuero MS; Bóveda JL; Carpio N; Contreras E; Fernández-Mondéjar E; Forteza A; García-Erce JA; García de Lorenzo A; Gomar C; Gómez A; Llau JV; López-Fernández MF; Moral V; Muñoz M; Páramo JA; Torrabadella P; Quintana M; Sánchez C
    Med Clin (Barc); 2006 Jul; 127 Suppl 1():3-20. PubMed ID: 17020674
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Conservation of blood during cardiovascular surgery.
    Cooley DA
    Am J Surg; 1995 Dec; 170(6A Suppl):53S-59S. PubMed ID: 8546249
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Drugs to reduce transfusion needs during surgery].
    Pleym H
    Tidsskr Nor Laegeforen; 2008 Apr; 128(7):829-30. PubMed ID: 18389031
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Critical evaluation of blood-saving measures for high-risk patients.
    Hartmann T; Winkler M; Preis C; Germann P; Donner A; Müller C
    Acta Anaesthesiol Scand Suppl; 1997; 111():207-9. PubMed ID: 9421015
    [No Abstract]   [Full Text] [Related]  

  • 6. [Jehovah's Witnesses refusal of blood: religious, legal and ethical aspects and considerations for anesthetic management].
    Pérez Ferrer A; Gredilla E; de Vicente J; García Fernández J; Reinoso Barbero F
    Rev Esp Anestesiol Reanim; 2006 Jan; 53(1):31-41. PubMed ID: 16475637
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Rational treatment of uncontrollable, life-threatening hemorrhage with recombinant factor VIIa].
    Stensballe J; Lethagen S; Lippert F; Johansson PI;
    Ugeskr Laeger; 2005 Jun; 167(25-31):2756-9. PubMed ID: 16014259
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Treatment of uncontrollable, life-threatening hemorrhage].
    Stensballe J; Lethagen S; Johansson PI
    Ugeskr Laeger; 2005 Jun; 167(25-31):2789-90. PubMed ID: 16014269
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Patient education about autologous blood donation].
    Weissauer W
    Infusionsther Transfusionsmed; 1996 Apr; 23(2):66. PubMed ID: 8777362
    [No Abstract]   [Full Text] [Related]  

  • 10. [Current legal questions in relation to autologous blood transfusion and legally controlled blood donation in Germany].
    Biermann E
    Infusionsther Transfusionsmed; 1994 Nov; 21 Suppl 3():6-11. PubMed ID: 7841782
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transfusion avoidance in orthopedic surgery.
    Cushner FD
    J Cardiothorac Vasc Anesth; 2004 Aug; 18(4 Suppl):29S-30S. PubMed ID: 15368203
    [No Abstract]   [Full Text] [Related]  

  • 12. [Combined erythropoietin and aprotinin use for blood conservation in elderly coronary bypass patients].
    Oshima N; Kiyama H; Imazeki T
    Kyobu Geka; 1997 Jul; 50(8 Suppl):707-10. PubMed ID: 9251499
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Problems of intraoperative blood loss and application of modern blood-saving techniques in neuroanesthesiology].
    Lubnin AIu; Gromova VV
    Anesteziol Reanimatol; 2003; (3):26-30. PubMed ID: 12918197
    [No Abstract]   [Full Text] [Related]  

  • 14. The use of technologies to decrease peri-operative allogenic blood transfusion: results of practice variation in Israel.
    Katz E; Gaitini L; Samri M; Egoz N; Fergusson D; Laupacis A
    Isr Med Assoc J; 2001 Nov; 3(11):809-12. PubMed ID: 11729574
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Blood substitution in surgery].
    Bardenheuer M; Frilling A; Massoudy P; Waydhas C; Nast-Kolb D
    Chirurg; 2001 Oct; 72(10):1206-19; quiz 1220-1. PubMed ID: 11715626
    [No Abstract]   [Full Text] [Related]  

  • 16. [Leucodepletion and autologous blood transfusion].
    García Erce JA; Muñoz Gómez M
    Med Clin (Barc); 2002 Jun; 119(4):138-9. PubMed ID: 12106525
    [No Abstract]   [Full Text] [Related]  

  • 17. [Blood transfusion in surgery: can it still be reduced by human recombinant erythropoietin?].
    Janvier G; Roth C; Bénillan N; Fialon P; Berty A; Puntous M
    Ann Fr Anesth Reanim; 1996; 15(8):1219-29. PubMed ID: 9636798
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [3rd International Symposium "Autologous transfusion--from euphoria to rational: practical handling from the scientific viewpoint" (Part I)].
    Singbartl G; Schleinzer W
    Anasthesiol Intensivmed Notfallmed Schmerzther; 2004 Sep; 39(9):556-8. PubMed ID: 15334333
    [No Abstract]   [Full Text] [Related]  

  • 19. [Effect of preoperative treatment with recombinant human erythropoietin in patients undergoing hemodilutional autologous transfusion].
    Nakae Y; Sonoda H; Miyabe M; Kawamata M; Sakakibara N; Kawana S; Namiki A
    Masui; 1995 Oct; 44(10):1362-8. PubMed ID: 8538004
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alternatives to allogeneic blood use in surgery: acute normovolemic hemodilution and preoperative autologous donation.
    D'Ambra MN; Kaplan DK
    Am J Surg; 1995 Dec; 170(6A Suppl):49S-52S. PubMed ID: 8546248
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.